Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers

Taylor and Francis Group, Expert Opinion on Drug Delivery, 7(17), p. 1025-1039, 2020

Journal article published in 2020 by Veronica Chierici

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by